MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ZIOPHARM Oncology Company Profile (NASDAQ:ZIOP)

Consensus Ratings for ZIOPHARM Oncology (NASDAQ:ZIOP) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $11.13 (50.54% upside)

Analysts' Ratings History for ZIOPHARM Oncology (NASDAQ:ZIOP)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Griffin SecuritiesReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Wells FargoReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016MizuhoBoost Price TargetNeutral$6.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$15.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha